Advertisement
UK markets open in 3 hours 10 minutes
  • NIKKEI 225

    37,952.52
    +324.04 (+0.86%)
     
  • HANG SENG

    17,586.87
    +302.33 (+1.75%)
     
  • CRUDE OIL

    83.79
    +0.22 (+0.26%)
     
  • GOLD FUTURES

    2,345.00
    +2.50 (+0.11%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,547.78
    +22.35 (+0.04%)
     
  • CMC Crypto 200

    1,390.24
    +7.66 (+0.55%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Pfizer on the Street: Analyst Recommendations in February 2018

Pfizer on the Street: Analyst Recommendations in February 2018

According to the terms of the agreement, Sangamo Therapeutics will receive an upfront payment of $12 million from Pfizer. Sangamo, using its ZFP-TF platform, will develop ZFP-TF candidates, while Pfizer will undertake operational and financial responsibilities for the further research and development, manufacturing, and commercialization of the ZFP-TF program.